Israel Englander Savara Inc Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Savara Inc stock. As of the latest transaction made, Millennium Management LLC holds 77,200 shares of SVRA stock, worth $294,904. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,200

Holding current value

$294,904

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.66 - $5.34 $107,658 - $157,076	29,415 New	29,415 $118,000
Q4 2023 Feb 14, 2024	BUY	$3.18 - $4.9 $3.32 Million - $5.11 Million	1,042,902 New	1,042,902 $4.9 Million
Q1 2023 May 15, 2023	BUY	$1.6 - $2.82 $1.08 Million - $1.91 Million	676,988 Added 371.09%	859,418 $1.68 Million
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.64 $76,511 - $113,043	68,929 Added 60.73%	182,430 $283,000
Q3 2022 Nov 14, 2022	SELL	$1.36 - $1.88 $58,225 - $80,488	-42,813 Reduced 27.39%	113,501 $176,000
Q2 2022 Aug 15, 2022	BUY	$1.1 - $1.58 $18,802 - $27,006	17,093 Added 12.28%	156,314 $238,000
Q1 2022 May 16, 2022	SELL	$1.05 - $1.36 $261,624 - $338,865	-249,166 Reduced 64.15%	139,221 $182,000
Q4 2021 Feb 14, 2022	BUY	$1.04 - $1.34 $45,164 - $58,192	43,427 Added 12.59%	388,387 $482,000
Q3 2021 Nov 15, 2021	SELL	$1.18 - $1.64 $1.9 Million - $2.64 Million	-1,609,854 Reduced 82.35%	344,960 $476,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $2.29 $2.2 Million - $3.33 Million	1,455,448 Added 291.46%	1,954,814 $3.32 Million
Q1 2021 May 17, 2021	BUY	$1.17 - $2.33 $584,258 - $1.16 Million	499,366 New	499,366 $1.04 Million
Q3 2020 Nov 16, 2020	SELL	$1.09 - $2.21 $612,359 - $1.24 Million	-561,798 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.8 - $3.05 $180,228 - $305,387	-100,127 Reduced 15.13%	561,798 $1.4 Million
Q1 2020 May 14, 2020	BUY	$1.91 - $4.08 $1.23 Million - $2.63 Million	643,931 Added 3578.59%	661,925 $1.4 Million
Q4 2019 Feb 14, 2020	SELL	$0.71 - $4.91 $51,075 - $353,215	-71,938 Reduced 79.99%	17,994 $81,000
Q3 2019 Nov 14, 2019	SELL	$2.16 - $3.2 $996,989 - $1.48 Million	-461,569 Reduced 83.69%	89,932 $238,000
Q2 2019 Aug 15, 2019	SELL	$2.37 - $11.7 $843,952 - $4.17 Million	-356,098 Reduced 39.24%	551,501 $1.31 Million
Q2 2019 Aug 14, 2019	BUY	$2.37 - $11.7 $1.8 Million - $8.88 Million	759,082 Added 511.11%	907,599 $17.9 Million
Q1 2019 May 14, 2019	BUY	$6.71 - $8.6 $363,359 - $465,707	54,152 Added 57.39%	148,517 $1.1 Million
Q4 2018 Feb 14, 2019	BUY	$6.27 - $10.92 $591,668 - $1.03 Million	94,365 New	94,365 $714,000
Q3 2018 Nov 14, 2018	SELL	$10.49 - $12.87 $1.58 Million - $1.94 Million	-150,416 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$8.55 - $13.76 $3.18 Million - $5.13 Million	-372,481 Reduced 71.23%	150,416 $1.7 Million
Q1 2018 May 15, 2018	BUY	$8.99 - $14.95 $4.33 Million - $7.2 Million	481,456 Added 1161.79%	522,897 $4.81 Million
Q4 2017 Feb 14, 2018	SELL	$8.26 - $16.76 $2.14 Million - $4.34 Million	-259,215 Reduced 86.22%	41,441 $615,000
Q3 2017 Nov 14, 2017	BUY	$5.1 - $9.55 $1.53 Million - $2.87 Million	300,656	300,656 $2.81 Million

Others Institutions Holding SVRA

# of Institutions

144

Shares Held

147M

Call Options Held

242K

Put Options Held

797K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $436M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account